| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 329 |
| 1 | TREPROSTINIL | 314 |
| 2 | SILDENAFIL CITRATE | 306 |
| 3 | MACITENTAN | 279 |
| 4 | TADALAFIL | 254 |
| 5 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 248 |
| 6 | FUROSEMIDE | 240 |
| 7 | AMBRISENTAN | 190 |
| 8 | SILDENAFIL | 179 |
| 9 | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 173 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 329 | 0.0251 |
| 1 | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 173 | 0.0193 |
| 2 | FOSCARBIDOPA/FOSLEVODOPA | 129 | 0.0146 |
| 3 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 248 | 0.0080 |
| 4 | IDURSULFASE | 24 | 0.0060 |
| 5 | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | 49 | 0.0060 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 48 | 0.0057 |
| 7 | LARONIDASE | 18 | 0.0044 |
| 8 | SOTATERCEPT-CSRK | 26 | 0.0042 |
| 9 | MACITENTAN | 279 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 615 |
| 1 | Endothelin Receptor Antagonist [EPC] | 463 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 352 |
| 3 | Corticosteroid [EPC] | 283 |
| 4 | Loop Diuretic [EPC] | 280 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 225 |
| 6 | Osmotic Laxative [EPC] | 168 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 160 |
| 8 | Benzodiazepine [EPC] | 153 |
| 9 | Aldosterone Antagonist [EPC] | 135 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 615 | 0.0045 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 53 | 0.0040 |
| 2 | GLP-2 Analog [EPC] | 53 | 0.0039 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 8 | 0.0033 |
| 4 | Autologous Cellular Immunotherapy [EPC] | 19 | 0.0033 |
| 5 | Provitamin D2 Compound [EPC] | 92 | 0.0031 |
| 6 | Vitamin D2 Analog [EPC] | 22 | 0.0031 |
| 7 | Human C1 Esterase Inhibitor [EPC] | 12 | 0.0031 |
| 8 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 9 | 0.0026 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 352 | 0.0026 |